Groups Tell 4th Circ. Not To Let Sandoz 'Relitigate' Enbrel
By Bryan Koenig · July 7, 2026, 5:57 PM EDT
Pharmaceutical groups and the Washington Legal Foundation backed Amgen in amicus briefs Monday urging the Fourth Circuit not to revive Sandoz's antitrust claims, arguing that if Sandoz wanted to litigate blocked...
To view the full article, register now.